Sugi Predict

Sugi Predict / Compounds / SCHEMBL737052

SCHEMBL737052

SCHEMBL737052

O=C(Cl)/C=C/c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 7/20 0.62
▸ MAOA P21397 5/20 0.62
▸ BCHE P06276 1/20 0.61
▸ MEN1 O00255 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ APP P05067 1/20 0.58
▸ CYP1B1 Q16678 1/20 0.57
▸ FBP1 P09467 2/20 0.56
▸ LMNA P02545 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ POLB P06746 2/20 0.55
▸ HSPD1 P10809 1/20 0.55
▸ HSPE1 P61604 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ PTGS1 P23219 1/20 0.54
▸ PTGS2 P35354 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL737053 1.00 MAOB (0.62) MAOBMAOABCHEMEN1KMT2A
SCHEMBL7733703 0.89 LMNA (0.55) MAOBMAOABCHEMEN1KMT2A
SCHEMBL11702342 0.85 MEN1 (0.69) MAOBMAOABCHEMEN1KMT2A
SCHEMBL9778220 0.85 MEN1 (0.69) MAOBMAOABCHEMEN1KMT2A
SCHEMBL27971259 0.83 MAOB (0.63) MAOBMAOABCHEMEN1KMT2A
SCHEMBL277169 0.83 MEN1 (0.71) MAOBMAOABCHEMEN1KMT2A
SCHEMBL27888906 0.83 MAOB (0.63) MAOBMAOABCHEMEN1KMT2A
SCHEMBL42325 0.83 MEN1 (0.71) MAOBMAOABCHEMEN1KMT2A
SCHEMBL2266597 0.82 CYP1A2 (0.56) MAOBLMNAMAPTPTGS2ALDH1A1
SCHEMBL2266594 0.82 CYP1A2 (0.56) MAOBLMNAMAPTPTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0440329-A1 S-substituted carbonyl substituted betathioacrylamide biocides and fungicides ROHM AND HAAS COMPANY (US) 1991-08-07 — — EP claimed
CN-118697737-A Application of piperlonguminine analogue compound in preparation of medicines for treating cervical cancer and/or liver cancer 赣南医学院第一附属医院 2024-09-27 — — CN disclosed
CN-114230519-B Pleuromutilin cinnamate compounds with drug-resistant bacteria resisting activity, and synthetic method and application thereof 西咸新区沣厚原创医药科技有限公司 2024-06-04 — — CN disclosed
US-11872202-B2 Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2024-01-16 — — US disclosed
US-11872202-B2 Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2024-01-16 — — US disclosed
US-20230172889-A1 PLEUROMUTILIN CINNAMIC ACID ESTER COMPOUNDS WITH ACTIVITIES AGAINST ANTIBIOTIC-RESISTANT INFECTIONS SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2023-06-08 — — US disclosed
US-20230172889-A1 PLEUROMUTILIN CINNAMIC ACID ESTER COMPOUNDS WITH ACTIVITIES AGAINST ANTIBIOTIC-RESISTANT INFECTIONS SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2023-06-08 — — US disclosed
CN-111153898-B Thiourea derivative and preparation method and application thereof 南华大学 2022-11-11 — — CN disclosed
CN-114230519-A Pleuromutilin cinnamate compounds with drug-resistant bacterium resisting activity and synthesis method and application thereof 陕西科技大学 2022-03-25 — — CN disclosed
CN-111153898-A Thiourea derivative and preparation method and application thereof 南华大学 2020-05-15 — — CN disclosed
EP-0047119-A1 Carboxamide compounds as SRS-A antagonists, pharmaceutical compositions containing them, processes for the preparation, and intermediates useful therein PFIZER INC. (US) 1982-03-10 — — EP disclosed
US-4296120-A ANTIANAPHYLACTIC PFIZER INC. (US) 1981-10-20 — — US disclosed
US-4296129-A ANTIAASTHMATIC INHIBITOR OF SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS PFIZER, INC. (US) 1981-10-20 — — US disclosed
US-4267354-A ANTIARRTHRITIC AGENTS; AMINOALKYLOXY-SUBSTITUTED BENZAMIDES OR -SULFONAMIDES E. R. SQUIBB & SONS, INC. (US) 1981-05-12 — — US disclosed
US-4216335-A ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1980-08-05 — — US disclosed
US-4182897-A ENZYME INHIBITORS FOR PROTEOLYTIC ENZYMES TORII & CO., LTD. (JP) 1980-01-08 — — US disclosed
US-4166072-A SUBSTITUTED AMIDES HAVING ANTIINFLAMMATORY ACTIVITY E. R. SQUIBB & SONS, INC. (US) 1979-08-28 — — US disclosed
US-4098789-A ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1978-07-04 — — US disclosed
US-RE28806-E Liquid crystal compositions XEROX CORPORATION (US) 1976-05-11 — — US disclosed
US-3931041-A LIQUID CRYSTAL COMPOSITIONS XEROX CORPORATION (US) 1976-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172889-A1 PLEUROMUTILIN CINNAMIC ACID ESTER COMPOUNDS WITH ACTIVITIES AGAINST ANTIBIOTIC-RESISTANT INFECTIONS RELA, PLEC, ABL1 MAOB 3262/4885MAOA 3399/4885BCHE 1693/4885
US-11872202-B2 Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections RELA, PLEC, ABL1 MAOB 3262/4885MAOA 3399/4885BCHE 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.